MedPath

Endoscopic Combined Intrarenal Surgery vs. Percutaneous Nephrolithotomy for Treatment of Staghorn Calculi

Not Applicable
Recruiting
Conditions
Urinary Calculi
Interventions
Procedure: Combined Intrarenal Surgery and percutaneous nephrolithotomy
Registration Number
NCT06519812
Lead Sponsor
Al-Azhar University
Brief Summary

This is a prospective randomized study to compare endoscopic combined intrarenal surgery and PCNL as modalities of treatment for staghorn stones. In terms of efficacy and safety

Detailed Description

This is a prospective randomized study to compare endoscopic combined intrarenal surgery and PCNL as modalities of treatment for staghorn stones. In terms of efficacy and safety The efficacy will be studied at stone-free rate While efficacy will be studied using DMSA scan pre- and post-procedures in addition to the safety of each procedure with regard to intra- and post-operative complications,.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Patients are more than 18 and less than 65 years old.
  • Patients with renal staghorn stones based on imaging modalities (stones occupying the renal pelvis and extending into at least 2 major calyces).
Exclusion Criteria
  • Patients with renal insufficiency (serum creatinine > 1.6 mg/dl)
  • patients with active urinary tract infection.
  • Patients with congenital renal anomalies.
  • Morbid obesity (BMI > 35 kg/m2).
  • Pregnancy.
  • Bleeding Coagulopathy.
  • Skeletal deformity

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group II (ECIRS group)Combined Intrarenal Surgery and percutaneous nephrolithotomy50 patients will undergo endoscopic combined intrarenal surgery (ECIRS).
• Group I (PCNL group)Combined Intrarenal Surgery and percutaneous nephrolithotomy50 patients will undergo percutaneous nephrolithotomy (PCNL).
Primary Outcome Measures
NameTimeMethod
stone-free rate3 months postoperative

Stone-free is defined as no residual stones on CT-UT or clinically insignificant residual fragments (CIRF) less than 4 mm in diameter.

It will be measured twice, first immediately postoperatively, and then again after 3 months of the procedure.

Secondary Outcome Measures
NameTimeMethod
Safety of the procedureintraoperative, early (in the first day postoperative) and late complications (3 months after the surgery).

Intra and post-operative complications

Trial Locations

Locations (1)

Al-Azhar University Hospital (New Damietta)

🇪🇬

Damietta, Egypt

© Copyright 2025. All Rights Reserved by MedPath